Skip to content

Application of acupuncture based on patient report outcome in the treatment of cervical spondylopathy

Application of acupuncture based on patient report outcome in the treatment of cervical spondylopathy

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001379
Enrollment
Unknown
Registered
2011-06-06
Start date
2011-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical spondylopathy

Interventions

Group A:sham acupuncture
Group B:traditional acupuncture
Group C:abdominal acupuncture

Sponsors

the Second Affiliated Hospital of Guangzhou University of TCM.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Male and female aged 18 to 60 years old; 2. Neck pain and rigid happened more than 1 time every month, symptoms last more than 6 months; 3. Positive signs of musculoskeletal system could be found by physical examination; 4. 3<Visual analog scale (VAS) score<7; 5. Haven't accepted acupuncture treatment in the last 6 months; 6. To be able to and willing to provide signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Neck injury history, or thoracic T1-T6 injury history; 2. Neurologic deficits; 3. Congenital vertebral anomaly; 4. Systemic bone or joint disease; 5. Be afraid of acupuncture; 6. Pregnant or lactating women; 7. Serious heart, brain, lung, kidney and other major medical disease and cancer patients.

Design outcomes

Primary

MeasureTime frame
Neck Disability Index Questionnaire;Northwick Park Neck Pain Questionnaire;the Medical Outcomes Study Short Form 36-items Health Survey (SF-36);

Secondary

MeasureTime frame
Visual Analog Scale;

Countries

China

Contacts

Public ContactZhaohui Liang
liang_zhao_hui@163.com+86 13711120596

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026